Recurrent Adult Immunoblastic Large Cell Lymphoma Withdrawn Phase 2 Trials for DB00531 (Cyclophosphamide)

IndicationStatusPhase
DBCOND0028500 (Recurrent Adult Immunoblastic Large Cell Lymphoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment